I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
We offer high-throughput solutions for immunity profiling and characterization of your model. This includes
For any scientific, technological or strategy guidance, please do not hesitate to contact PHENOMIN experts.
We have developped a preclinical pipeline and thanks to the viral particles, COVID-19 mouse models, cohort production and BSL3 pipeline analysis we provide to you, you will be bale to assess a novel potential vaccine and treatment compounds for COVID-19. Further functional analysis and advanced readouts like organ histopathological analysis, multiplex assay profiling of cytokines and chemokines in lung and mouse serum etc. can be provided upon request too. A final infection profile report will be provided as a deliverable.
The aim of this project is to gain insight into the number of markers expressed in different leukocytes in mice of different immune status. One of the main question is which markers are highly or slightly expressed relative to others, and in which subset ? That’s the value of such a resource ! A lot of markers are not expressed in mouse at basal level, therefore standardized protocols have been set up to challenge the immune system of the mice. This ressource will help designing rational mAb panels working during an inflammation. For more information, have a look to the interview of H. Luche (Flowcytometry news, Oct. 2018)
|
Biosample collection |
Automated cell extraction |
Cell suspension or Cell enrichment | |||
experimental groups - up to 24 individuals
|
up to 4 tissues
|
up to 24 sampes at once
|
||||
EX VIVO ASSAYS
|
IN VIVO ASSAYS Activation & Differentiation (B, T, NK cells)
Cytokine, Chemokine multiplex Immuno assays
CELL BANKING Basal & Activated states
|
INTEGRATED DATA ANALYSIS
IMMUNE ORGANS
|
HIGH CONTENT PANELS
|
||
Blood
Thymus
Spleen / Lymphe Node
Bone marrow
Peritoneum
Lung
Intestin
|
PERIPHERAL BLOOD
Quantitative analysis of hematopoietic cells
|
13 populations
|
|
THYMUS
T cell development
Dendritic cells
|
17 populations
19 populations
|
||
SPLEEN / LYMPHE NODE
Orientation panel
L-T/NK panel
L-B panel
Myeloid panel
Dendritic panel
|
34 populations
53 populations
15 populations
19 populations
19 populations
|
||
CELL TYPES
|
|||
LYMPHOCYTES
T cells
B cells
NK cells
MYELOID CELLS
Monocytes
Neutrophils/Basop
Eosinophils/Mast
Macrophages
DC, pDC
|
BONE MARROW
Stem cells / Myeloid cells precursors
B cell development
|
|
|
LUNG (broncho-alveolar lavage)
Steady state/ inflammation
|
17 populations
|
||
PERITONEAL CAVITY
Steady state/ inflammation
|
17 populations
|
||
Quantitative measurement of MARKER EXPRESSION
|
20 populations
|
||
DESIGN PANEL & CONSULTING
|
|
.
Tracking & characterizing immunity in infected mouse models |
Monitoring infection progression |
Delivery of key analysis endpoints |
INFECTION MONITORING
• CTRL
• GEM
• HUMANIZED
Acute & Chronic Infection
|
EX VIVO ASSAYS PATHOGEN COLONIZATION
CFU
INNATE & ADAPTATIVE IMMUNITY
Cell sorting of infected cells
Immunophenotyping
Serum released cytokines & chemokines profiling
Immune cells stimulation with pathogen antigens
ANATOMOPATHOLOGY
Confocal imaging
Tissues cryosection
Histology H&E
Tissues bioluminescence
|
|||
IN VIVO ASSAYS INFECTION PROGRESSION
Bioluminescence imaging
Bi-Photon microscopy
CLINICAL READOUTS
Survival curves
Body weight loss & temperature
Distress
|
CLASS II / III PATHOGENS (bacteria, virus, parasites, fungi)
BSL3
Challenge / Infection Assays
PATHOGEN DETECTION & ANALYSIS
|
IMMUNO-PHENOTYPING
INNATE & ADAPTATIVE RESPONSES
|
Bacteria, viruses, fungi, parasites
Dendritic cell
|
Naive CD4+ TH cell
|
IL-12
|
TH 1
STAT4/TBX21
|
IFNg |
Cellular Immunity
|
|||
IL-4
|
TH 2
STAT6/GATA3
|
IL-4
IL-5
IL-13
|
Humoral Immunity Allergy
|
|||||
IL-6
IL-21
IL-23
|
TH 17
STAT6/RORd /RORg
|
IL-17
IL-22
IL-21
|
Inflammation
Autoimmunity
|
|||||
IL-2
TGFb1
ATRA
|
TrREG
|
IL-10
TGFb
|
Immune Tolerance
|
Inflammation
Immuno-Oncology
Infection
Controlling infectious diseases requires understanding of the relationships between immune cells and pathogens.
Most current studies to understand infectious processes rely on models requiring
The Biosafety Level 3 Containment Facility (BSL3) has special engineering and containment features that allow investigators to work safely with pathogens classified as risk group 2 or 3. This facility consists of three laboratory suites corresponding to an animal housing room, a laboratory for in vitro experiments and a bio-imaging area.
All instruments are accessible to trained users based on the scientific and regulatory rules established by scientific and biosecurity and safety manager of BSL3. Although the BSL3 platform was only fully operational in May 2015, it already permitted to set up
Real-time imaging studies of immune responses in mice challenged by pathogens such as Salmonella or Brucella infection have led to the development of an immunophenotyping analytical pipeline devoted to infection in synergy with our Immunophenotyping module. The analysis of organ distribution of biomolecules engineered to transport and deliver nucleic acids on living animals using an IVIS Lumina III device is also developed in the frame of a contract with a biotech company. Therefore, we can visualize the spread of infection in vivo, isolate and characterize the pathogens, and analyze phenotypic and functional modification of immune system in the course of infections by advanced live-imaging and flow and mass cytometry.
We provide a broad range of instruments and services for academic and industrial customers. An experienced staff of scientists, technical experts and instrument specialist provides instructions for the design, execution and analysis of standardized multiparametric flow, spectral, mass cytometry and advanced microscopy based studies. All these cutting-edge equipment are technically and operationally enrolled in a regular maintenance program with their commercial providers. Moreover, instrument specialists at PHENOMIN are dedicated to the maintenance and tuning of the instruments on a daily basis. The characterization of the cytometer status and performance using CS&T beads for cytometer set up and tracking system, ensure reproducible performance and instrument sensitivity on a day to day basis. All experiments are standardized using applications setting in order to achieve: (1) high consistency of results over time and (2) facilitate data analysis and results validation. All data are archived and stored on dedicated servers. Depending on the technical complexity and availability, the equipment can be handled by our experts or made available for use to trained customers. PHENOMIN has set up an on line instrument tutorial for training external users. PHENOMIN applies two types of price: one for its academic clients on full cost basis and the other one for its industrial customers taking into consideration intellectual property and the transfer of know-how.
Real-time imaging studies of immune responses in mice challenged by pathogens (Salmonella infection model) and infection-immunophenotyping analysis pipeline in synergy with immunophenotyping CIPHE facility.
Set up vaccine assays and test the ability of adjuvants to enhance vaccine efficacy in a mouse model of infection.